Kenneth M. Williams

3.5k total citations
73 papers, 2.6k citations indexed

About

Kenneth M. Williams is a scholar working on Pharmacology, Pharmacology and Nephrology. According to data from OpenAlex, Kenneth M. Williams has authored 73 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 18 papers in Pharmacology and 14 papers in Nephrology. Recurrent topics in Kenneth M. Williams's work include Gout, Hyperuricemia, Uric Acid (14 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Inflammatory mediators and NSAID effects (9 papers). Kenneth M. Williams is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (14 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Inflammatory mediators and NSAID effects (9 papers). Kenneth M. Williams collaborates with scholars based in Australia, United States and South Korea. Kenneth M. Williams's co-authors include Richard O. Day, Andrew J. McLachlan, Edmund Lee, Garry G. Graham, Neal M. Davies, Winston Liauw, Sophie L. Stocker, Basil D. Roufogalis, Terence J. Campbell and Xuemin Jiang and has published in prestigious journals such as Analytical Chemistry, Clinical Infectious Diseases and British Journal of Pharmacology.

In The Last Decade

Kenneth M. Williams

72 papers receiving 2.5k citations

Peers

Kenneth M. Williams
Wichittra Tassaneeyakul Thailand
Roger K. Verbeeck Belgium
Fakhreddin Jamali Canada
Garry G. Graham Australia
Bikui Zhang China
George K. Dresser Canada
Aziz Karim United States
Toshinori Yamamoto Japan
Douglas H. Sweet United States
Hisakazu Ohtani Japan
Wichittra Tassaneeyakul Thailand
Kenneth M. Williams
Citations per year, relative to Kenneth M. Williams Kenneth M. Williams (= 1×) peers Wichittra Tassaneeyakul

Countries citing papers authored by Kenneth M. Williams

Since Specialization
Citations

This map shows the geographic impact of Kenneth M. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth M. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth M. Williams more than expected).

Fields of papers citing papers by Kenneth M. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth M. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth M. Williams. The network helps show where Kenneth M. Williams may publish in the future.

Co-authorship network of co-authors of Kenneth M. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth M. Williams. A scholar is included among the top collaborators of Kenneth M. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth M. Williams. Kenneth M. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Kenneth M., et al.. (2025). Role of P-Gp in Treatment of Cancer. Journal of Cancer Therapy. 16(1). 1–17.
2.
Carland, Jane E., Sophie L. Stocker, Melissa Baysari, et al.. (2021). Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices. British Journal of Clinical Pharmacology. 87(11). 4221–4229. 18 indexed citations
3.
Graham, Garry G., Sophie L. Stocker, Zhixin Liu, et al.. (2020). A pharmacokinetic‐pharmacodynamic study of a single dose of febuxostat in healthy subjects. British Journal of Clinical Pharmacology. 86(12). 2486–2496. 8 indexed citations
4.
Williams, Kenneth M., Garry G. Graham, Ross Norris, et al.. (2019). Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection. Journal of Chromatography B. 1126-1127. 121764–121764. 14 indexed citations
5.
Martinello, Marianne, Maryam Alavi, Kenneth M. Williams, et al.. (2015). The Impact of Ribavirin Plasma Concentration on the Efficacy of the Interferon-Sparing Regimen, Sofosbuvir and Ribavirin. Antiviral Therapy. 21(2). 127–132. 3 indexed citations
6.
Orozco, Adrián Flores, Matthias Bücker, & Kenneth M. Williams. (2014). Characterization of Natural Attenuation in a uranium-contaminated site by means of Induced Polarization Imaging. EGUGA. 8942. 1 indexed citations
7.
Stocker, Sophie L., Andrew J. McLachlan, Radojka M. Savić, et al.. (2012). The pharmacokinetics of oxypurinol in people with gout. British Journal of Clinical Pharmacology. 74(3). 477–489. 25 indexed citations
8.
Stocker, Sophie L., et al.. (2010). Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers. European Journal of Clinical Pharmacology. 67(7). 709–713. 1 indexed citations
9.
Stocker, Sophie L., Michael E. Franklin, John E. Anderson, et al.. (2010). Measurement of urinary oxypurinol by high performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 878(25). 2363–2368. 11 indexed citations
10.
Xu, Hongmei, Kenneth M. Williams, Winston Liauw, et al.. (2008). Effects of St John's wort andCYP2C9genotype on the pharmacokinetics and pharmacodynamics of gliclazide. British Journal of Pharmacology. 153(7). 1579–1586. 69 indexed citations
11.
Day, Richard O., Garry G. Graham, Mark Hicks, et al.. (2007). Clinical Pharmacokinetics and Pharmacodynamics of Allopurinol and Oxypurinol. Clinical Pharmacokinetics. 46(8). 623–644. 168 indexed citations
12.
Jiang, Xuemin, Kenneth M. Williams, Winston Liauw, et al.. (2005). Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology. 59(4). 425–432. 148 indexed citations
13.
Jiang, Xuemin, Kenneth M. Williams, Winston Liauw, et al.. (2004). Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology. 57(5). 592–599. 193 indexed citations
14.
Sasongko, Lucy, Kenneth M. Williams, Richard O. Day, & Andrew J. McLachlan. (2003). Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques. British Journal of Clinical Pharmacology. 56(5). 551–561. 26 indexed citations
15.
Davies, Neal M., Andrew J. McLachlan, Richard O. Day, & Kenneth M. Williams. (2000). Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib. Clinical Pharmacokinetics. 38(3). 225–242. 344 indexed citations
16.
Erb, Katharina, Roland Brugger, Kenneth M. Williams, & Gerd Geißlinger. (1999). Stereoselective disposition of tiaprofenic acid enantiomers in rats. Chirality. 11(2). 103–108. 7 indexed citations
17.
Scheuerer, Stefan, Stephen D. Hall, Kenneth M. Williams, & Gerd Geißlinger. (1998). Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers*. Clinical Pharmacology & Therapeutics. 64(2). 168–176. 12 indexed citations
18.
Williams, Kenneth M.. (1991). Molecular Asymmetry and Its Pharmacological Consequences. Advances in pharmacology. 22. 57–135. 10 indexed citations
19.
Day, Richard O., et al.. (1991). The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma. Arthritis & Rheumatism. 34(6). 751–760. 12 indexed citations
20.
Case, Emalani & Kenneth M. Williams. (1978). QUEEN ELIZABETH WAY FREEWAY SURVEILLANCE AND CONTROL SYSTEM DEMONSTATION PROJECT. Transportation Research Record Journal of the Transportation Research Board. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wichittra Tassaneeyakul Breakdown of academic impact, for papers by Roger K. Verbeeck Breakdown of academic impact, for papers by Fakhreddin Jamali Breakdown of academic impact, for papers by Garry G. Graham Breakdown of academic impact, for papers by Bikui Zhang Breakdown of academic impact, for papers by George K. Dresser Breakdown of academic impact, for papers by Aziz Karim Breakdown of academic impact, for papers by Toshinori Yamamoto Breakdown of academic impact, for papers by Douglas H. Sweet Breakdown of academic impact, for papers by Hisakazu Ohtani
Rankless by CCL
2026